- Home
- JELD vs PYPD Comparison
JELD vs PYPD Comparison
Compare JELD & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JELD | PYPD |
|---|---|---|
| Founded | 1960 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Forest Products | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.9M | 81.7M |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | JELD | PYPD |
|---|---|---|
| Price | $1.14 | $4.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $3.43 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.1M | 55.2K |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,211,181,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.93 | $2.44 |
| 52 Week High | $6.98 | $5.12 |
Technical Indicators
Market Signals| Indicator | JELD | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 51.00 |
| Support Level | N/A | $4.14 |
| Resistance Level | $2.06 | $4.38 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 54.55 | 65.91 |
Price Performance
Historical ComparisonAbout JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.